Spreafico, M <br/><br/>
Warfarin and acenocoumarol dose requirements according to CYP2C9 genotyping in North-Italian patients.  [electronic resource] 

 -  Journal of thrombosis and haemostasis : JTH  Oct 2003 
 - 2252-3 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1538-7933 
<br/><br/><label>Standard No.: </label>10.1046/j.1538-7836.2003.00442.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acenocoumarol--administration & dosage<br/>Alleles<br/>Anticoagulants--administration & dosage<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Cytochrome P-450 CYP2C9<br/>Gene Frequency<br/>Genotype<br/>Humans<br/>Italy<br/>Polymerase Chain Reaction<br/>Thromboembolism--genetics<br/>Warfarin--administration & dosage